Clinical Trial Update: Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results [NA]

View source ↗

Summary

This clinical trial explores treating refractory breast cancer using organoid drug sensitivity results to guide therapy; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Refractory Breast Cancer | NA | Status: NOT_YET_RECRUITING